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Abstract
Objective—To apply phenotypic and statistical methods designed to account for heterogeneity to 
linkage analyses of the autism Collaborative Linkage Study of Autism (CLSA) affected sibling 
pair families.
Method—The CLSA contains two sets of 57 families each; Set 1 has been analyzed previously, 
whereas this study presents the first analyses of Set 2. The two sets were analyzed independently, 
and were further split based on the degree of phrase speech delay in the siblings. Linkage analysis 
was carried out using the posterior probability of linkage (PPL), a Bayesian statistic that provides 
a mathematically rigorous mechanism for combining linkage evidence across multiple samples.
Results—Two-point PPLs from Set 1 led to the follow-up genotyping of 18 markers around 
linkage peaks on 1q, 13p, 13q, 16q, and 17q in both sets of families. Multipoint PPLs were then 
calculated for the entire CLSA sample. These analyses identified four regions with at least modest 
evidence in support of linkage: 1q at 173 cM, PPL = 0.12; 13p at 21 cM, PPL = 0.16; 16q at 63 
cM, PPL= 0.36; Xq at 40 cM, PPL = 0.11.
Conclusion—We find strengthened evidence for linkage of autism to chromosomes 1q, 13p, 
16q, and Xq, and diminished evidence for linkage to 7q and 13q. The verity of these findings will 
be tested by continuing to update our PPL analyses with data from additional autism datasets.
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Autism is a developmental disorder characterized by impairments in language and social 
interaction and by excessively repetitive and ritualistic behaviors. Onset is before the age of 
three, and though the constellation and severity of symptoms may change over time, they 
typically persist in some form throughout life. Family and twin studies have shown that 
autism susceptibility is attributable primarily to genetic factors, with a heritability estimate 
that approaches 90% and a sibling relative risk of 25–50 (Folstein and Rutter, 1977; Bailey 
et al., 1995; Pickles et al., 1995; Szatmari et al., 1998; Risch et al., 1999). Linkage studies 
have been a primary means of searching for susceptibility genes (IMGSAC, 1998; CLSA, 
1999; Philippe et al., 1999; Risch et al., 1999; Liu et al., 2001; Alarcon et al., 2002; 
Auranen et al., 2002; Shao et al., 2002b; Yonan et al., 2003). Our research group, the 
Collaborative Linkage Study of Autism (CLSA), carried out one of these, genotyping 350 
markers in 75 autism affected sibling pair (ASP) families (CLSA, 1999). The strongest 
linkages that we reported were multipoint heterogeneity logarithm of the odds (LOD) scores 
of 3.0 at 55 cM on chromosome 13, 2.3 at 19 cM on chromosome 13, and 2.2 at 110 cM on 
chromosome 7 (cM distances are from the Marshfield sex-averaged genetic map). Other 
similar studies have also generally yielded modest evidence for linkage at multiple loci, 
replication across studies has been limited, and in studies with expanding samples the 
locations and strengths of linkages have often changed, so that it is unclear whether any 
single locus has yet been definitively confirmed (Wassink et al., 2004).
The heterogeneity of autism is likely to underlie much of this impasse. Family and twin 
studies suggest that autism arises from interactions of multiple genetic variants, and that 
different combinations of variants may be causative in different groups of people. We are 
likely, therefore, to be pooling under the diagnosis of autism multiple etiologies that should 
instead be distinguished from one another. Even with improved phenotyping, however, the 
power of our analyses is diminished by statistical methods that do not appropriately model 
heterogeneity. Traditional LOD score and model-free methods either merge multiple 
subgroups into one ‘pooled’ analysis or analyze the subgroups independently. In the 
presence of heterogeneity, true linkages from independent samples can be obscured by 
pooling (Huang and Vieland, 2001; Vieland et al., 2001), whereas treating subgroups 
separately constitutes a form of maximization over the phenotype that can artificially inflate 
evidence for linkage (Weeks et al., 1990).
In our initial linkage screen, therefore, we tested on a limited scale what were at the time 
novel phenotypic and statistical strategies designed to address heterogeneity. First we 
reanalyzed the CLSA linkage data from the 7q and 13q loci using language characteristics to 
enrich the phenotype (CLSA et al., 2001). Families were classified as phrase speech delay 
(PSD) ‘positive’ if at least two autistic children had failed to develop phrase speech by 36 
months, and otherwise as PSD ‘negative’ (the average normal onset of phrase speech is 18 
months; 2/3 of families were PSD positive). Analyses of the two subgroups revealed that the 
predominance of the 7q and 13q linkage signals arose from the PSD positive families, a 
pattern subsequently observed in other autism linkage studies (Buxbaum et al., 2001; Shao 
et al., 2002a).
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In addition, we had assessed by direct questioning whether the CLSA parents had a history 
of developmental language difficulties, including delayed onset of speech, trouble learning 
to read, or persistent trouble with spelling. Parents who experienced any of these difficulties 
were classified as ‘language impaired’ (affected) and otherwise as ‘language normal’ 
(unaffected). Incorporation of these phenotypes into the analyses strengthened the evidence 
for linkage at the 7q and 13q loci in the PSD positive families. These results thus supported 
the hypotheses that: (i) language based classification defines more homogeneous subgroups 
of families with autism, and (ii) parental language phenotype is in some way genetically 
related to autism.
To address the analytical challenge posed by heterogeneity, we turned to the posterior 
probability of linkage (PPL) statistic (Vieland, 1998). The PPL is a Bayesian statistic that is 
essentially model-free. It is calculated on the probability scale (0, 1), so that a value of 0.60 
(60%) indicates a 60% probability of linkage at a particular locus. The PPL produces 
significantly diminished ‘noise’ in comparison to traditional LOD score and nonparametric 
statistics and, of import for our analyses, provides a mathematically rigorous mechanism for 
integrating evidence for or against linkage across multiple samples and subgroups of 
families (Vieland et al., 2001; Logue et al., 2003; Logue and Vieland, 2004). The efficacy of 
the PPL has been demonstrated in both simulated and real datasets (Wang et al., 1999; 
Huang and Vieland, 2001; Vieland et al., 2001; Bartlett et al., 2002, 2004; Logue et al., 
2003), and we recently carried out a PPL analysis of genotyping data from a large, publicly 
available collection of autism families – the Autism Genetics Resource Exchange (AGRE) 
sample – using both diagnosis and language based subgrouping (Bartlett et al., 2005).
In this report, we expand implementation of these phenotypic and statistical strategies to 
encompass the entire CLSA sample. We also present analyses of new genotyping in 
chromosomal regions of interest in a second set of CLSA families not previously described.
Methods
Collaborative Linkage Study of Autism families
Families for the CLSA were recruited from the Midwest and Mid-Atlantic United States 
through data collection sites at the University of Iowa and the University of North Carolina, 
as described in our original report (CLSA, 1999). All affected individuals were at least 3 
years old and were required to meet the Autism Diagnostic Interview, Revised (Lord et al., 
1994) and the Autism Diagnostic Observation Schedule (Lord et al., 1989) or Autism 
Diagnostic Observation Schedule–Generic (Lord et al., 2000) criteria for autism. Affecteds 
were excluded if they had fragile X syndrome (based on fragile X DNA testing), or any 
other neurological or medical condition suspected of being associated with autism. DNA 
was extracted from whole blood using standard techniques.
Our initial study reported on a total of 75 ASP families gathered in this way; 18 of these 
families were provided through a previous collaboration and are no longer available, leaving 
57 families as Set 1. We have since enrolled another 57 families that are contained within 
Set 2, providing a total of 114 CLSA ASP families for analysis.
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Language subsetting of the data
The Set 1 and 2 families were each split in two, being classified as PSD positive if at least 
two autistic children had failed to develop phrase speech by 36 months, and otherwise as 
PSD negative, creating a total of four separate subgroups for analysis. Parents were coded as 
affected or unaffected based on a history of developmental language problems. The numbers 
of families and PSD positive parents in each group are shown in Table 1. No notable 
differences in the proportions of these classifications or any other demographic or 
phenotypic characteristics between the Set 1 and 2 families were observed.
Genotyping
A total of 383 short tandem repeat polymorphism markers representing a modified version 
of Weber set 8 (http://research.marshfieldclinic.org/genetics/sets/Set8ScreenFrames.htm) 
were genotyped in the Set 1 families in our initial genome screen (CLSA, 1999). 
Genotyping had been carried out using standard PCR protocols with products visualized 
using silver stained polyacrylamide gels. Since that time, additional markers had been 
genotyped in regions of interest arising from the initial study. In the course of this follow-up, 
some of the original markers were regenotyped to confirm the data. This genotyping 
revealed that a number of the original markers had error rates ranging from 5–10%. Further 
assessment revealed that the problematic markers all came from one genotyping site. We 
therefore had all markers from that site – approximately 190 – regenotyped by Weber 
Genotyping Service using the same or nearby markers from Weber set 13. From the two-
point PPL analysis of CLSA Set 1 (described below), we selected five regions for follow-up 
study (1q, 13p, 13q, 16q, and 17q).
For each region, we genotyped the peak marker in the Set 2 families, and additional flanking 
markers in the combined Set 1 and 2 families. Ten additional markers were genotyped in the 
chromosome 16 region, whereas one marker was genotyped on each side of the peak in the 
other four regions. Thus a total of 18 new markers were genotyped in both sets of families, 
and in addition the five peak markers were genotyped in the Set 2 families (marker 
information available upon request). PCR was carried out with 20 ng of genomic DNA 
amplified in a reaction mixture containing 1.0 µl of PCR buffer [100 mmol/l Tris-HCl (pH 
8.8), 500 mmol/l KCl, 15 mmol/l MgCl2, 0.01% gelatine (w/v)], 200 µmol/l each of dATP, 
dCTP, dGTP, and dTTP, 2.5 pM of each primer, and 0.05 units of Taq DNA polymerase, 
increased to a final volume of 10.0 µl with water. Samples were initially denatured at 941 
for 3 min, followed by 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s. PCR 
products were then electrophoresed on 6% polyacrylamide gels at 60 W for approximately 2 
h and visualized with silver staining (Bassam et al., 1991). Gels were read blindly with 
respect to sample status by two independent raters, with discrepancies resolved by 
regenotyping.
Error checking was carried out using PedCheck (O’Connell and Weeks, 1998) to identify 
non-Mendelian transmissions and GeneHunter (Kruglyak et al., 1996) to identify double 
recombinants.
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Errors flagged in this way were regenotyped. Wherever an inconsistency persisted, alleles 
for that marker were zeroed out in the entire family from which the inconsistency arose. 
Marker allele frequencies were calculated by counting alleles in the founders separately for 
Set 1 and 2.
Linkage analysis
The PPL has been described in detail elsewhere (Vieland, 1998). In brief, the statistic is 
computed from the Bayes ratio, or the ordinary single-locus LOD score allowing for locus 
heterogeneity under the admixture model (Smith, 1963), with the trait parameters, including 
the admixture parameter, integrated out. As these parameters are integrated out rather than 
maximized over, we incur no ‘penalty’ or inherent inflation of the result owing to the 
inclusion of trait parameters in the model, nor do we need to ‘fix’ the values of the trait 
parameters. Thus, though it is based on a single-locus approximation to the true likelihood, 
the method is essentially model-free. In addition, because it is based on the full likelihood, 
phenotypic information on all family members is readily incorporated. In this analysis, we 
have assigned the phenotypes affected, unaffected, and unknown to parents based on the 
developmental language variable described above. The PPL itself is on the probability scale, 
converging to 1 (as a function of effective sample size) when there is linkage, and to 0 when 
there is no linkage (Wang et al., 2000). It incorporates a small 2% prior probability of 
linkage (Elston and Lange, 1975; Morton, 1998), so that a PPL greater than 0.02 indicates 
some degree of evidence in favor of linkage, whereas a PPL < 0.02 indicates evidence 
against linkage.
When analyzing multiple datasets or families divided into subgroups, the PPL passes 
forward the posterior distribution for the recombination fraction θ (for two-point analysis), 
or the location parameter (for multipoint analysis) derived from one dataset as the prior 
distribution for analysis of the next. This process is repeated as each new set of data is 
incorporated into the analysis. The PPL allows for between-group differences by integrating 
trait parameters out of the model independently for each data set, thus enabling accurate 
quantification of the posterior probability based on all of the data. The final value of the PPL 
is independent of the order in which the data sets are fed in to the calculation (Vieland et al., 
2001). In addition, dividing the data into subsets does not, in and of itself, affect the final 
value of the PPL. If data are grouped based on a genetically irrelevant feature, the PPL (on 
average) remains the same, as if no subsetting had been carried out. If, however, subsetting 
results in more homogeneous subgroups, the sequentially updated PPL will tend to be larger 
than a PPL carried out without subsetting.
We first report two-point results for CSLA Set 1 families, which entailed sequentially 
updating over PSD positive and PSD negative subsets. This serves primarily to allow 
comparison with our earlier results in a largely overlapping set of families. For multipoint 
PPL analysis, we incorporated the CLSA Set 2 PSD positive and negative families and 
walked down the chromosome in fixed 1 cM steps, sequentially updating the statistic across 
data sets at each location (Logue and Vieland, 2004).
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Two-point posterior probability of linkage analysis of Set 1 Collaborative Linkage Study of 
Autism families
Of the 383 markers analyzed in Set 1, 61 (16%) had PPLs greater than 2% (the initial prior 
probability of linkage), and only nine (2%) had PPLs of 10% or higher; 254 (66%) markers 
had PPLs less than 2%, indicating some degree of evidence against linkage. The nine 
markers with PPLs ≥ 10% were in six chromosomal regions: 1q, 13p, 13q, 16q, 17q, and X 
(Table 2). Two of these – ATA5A09N on chromosome 13p at 20 cM, and 13AL159 on 13q 
at 55 cM – corresponded to previously reported peak heterogeneity logarithm of the odds 
scores (HLODs) in this set of families (CLSA, 1999, 2001). The 1q, 16q, 17q, and X loci, 
however, were not suggested by our previous analyses, and the largest PPL on chromosome 
7 was 2%.
Multipoint posterior probability of linkage analysis of Set 1 and 2 families
Two-point PPLs of the follow-up markers showed no evidence for linkage in the second Set 
families (data not shown). Figure 1 shows a graph of the multi-point PPLs across the 
genome that incorporates the 18 follow-up markers and the Set 2 families (recall that we 
genotyped Set 2 only for these 18 markers, so that the remainder of the multipoint results 
reflect Set 1 alone). Approximately 69% of the genome shows PPLs less than 2%, whereas 
only 1.6% has PPLs ≥ 10%. Four peaks stand out: 1q, 13p, 16q, and X (Table 2 and Fig. 2). 
Not surprisingly, these peaks correspond to regions with the highest two-point PPLs. We 
note, however, that at every location the multipoint are smaller than the corresponding two-
point PPLs. This is not a general property of the PPL (Logue and Vieland, 2004), and we 
have carried out thorough error checking and regenotyping of peak markers to ensure 
accuracy of genotypes. The 17q multipoint PPL is just 6%, the 13q multipoint PPL is 4%, 
and the multipoint PPL on 16, whereas still the largest in the CLSA dataset (36% at 63 cM), 
is considerably smaller than the two-point PPL from the Set 1 families of 95%.
Overall, the Set 2 families contributed little to the signals in the regions of interest identified 
on the basis of the Set 1 families, which is consistent with the tendency of locus 
heterogeneity to make replication of any one locus in a second set of families improbable 
(Suarez et al., 1994; Vieland et al., 2001).
Discussion
We have carried out linkage analysis in a sample of autism affected sibling pair families 
using enriched phenotypic information. We have analyzed the resultant data using the PPL 
statistic, which is designed to rigorously assess evidence for or against linkage across 
multiple, potentially heterogeneous sets of data. The implementation of these methods 
reflects our efforts to account for and address the phenotypic and genetic heterogeneity of 
autism, with the result that previously unidentified regions of interest have emerged, 
whereas others have diminished.
From the original CLSA genome-wide linkage screen, the three strongest signals based on 
heterogeneity LOD score analyses were on 13q (HLOD = 3.0 at 55 cM), 7q (HLOD = 2.2 at 
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110 cM), and 13p (HLOD = 2.3 at 19 cM) (CLSA et al., 1999, 2001). In the new PPL 
analysis, the 13p signal remains substantial, the 13q signal is small, and no evidence for 
linkage exists on 7q. The differences in these results are likely to be owing to a combination 
of the factors that distinguish the current from the former study: (i) genome-wide application 
of language based classifications, (ii) genome-wide application of the PPL, (iii) 18 of the 
families from the original Set 1 are not in the current set, and (iv) a large subset of the 
screening markers were regenotyped.
The strongest evidence for linkage in the new analyses is to chromosome 16q (Table 2, Fig. 
2). This locus is substantially removed from chromosome 16 linkages identified in previous 
studies of autism (Philippe et al., 1999; Lucarelli et al., 2003; Barnby et al., 2005; Philippi 
et al., 2005), though a number of reports have described autistic individuals with 
chromosomal abnormalities near our peak (Hebebrand et al., 1994; Finelli et al., 2004). 
Candidate genes of interest in this region include SALL1, CBLN1, NKD1, N4BP1, and 
NETO2. The chromosome X linkage peak also appears to be novel, with only modest 
evidence for linkage to X having been previously reported at significant distances from our 
locus (Hallmayer et al., 1996; Liu et al., 2001; Shao et al., 2002b). Numerous genes on X 
have been tested as autism candidates, including ARX, MECP2, NLGN3, NLGN4, MAOA, 
MAOB, and FMR1. Of these, MAOA and MAOB at 43 MB are near our peak and may 
therefore warrant closer scrutiny in the CLSA families. The chromosome 1 locus overlaps 
with findings from a number of previous studies. Bartlett et al. reported a multipoint PPL of 
55% at 183 cM in the Autism Genetics Resource Exchange sample of families, and two 
studies from Finland – one of autism (Auranen et al., 2002) and the other of Asperger’s 
syndrome (Ylisaukko-oja et al., 2004) – found linkage to 1q markers at 165 and 170 cM, 
respectively. We also recently described, in an autistic proband, uniparental disomy of 
chromosome 1 with a region of isodisomy that overlaps this interval (Wassink et al., 2005). 
Lastly, the linkage signal on 13p, which was the most well-preserved from the original 
genome-wide screen, has not been reported in other linkage studies of autism.
Thus, we find new or strengthened evidence for linkage to specific loci on chromosomes 1q, 
13p, 16q, and Xq, and diminished or absent evidence for linkage to the previously identified 
7q and 13q loci. The ‘significance’ of these findings in more traditional LOD score and 
probability terms is difficult to determine. The PPL cannot be translated directly to a LOD 
score, and because the PPL is a Bayesian measure and thus conditioned on the observed 
data, it cannot be assigned a significance level, because a significance level describes the 
probability of the observed data given all possible outcomes (Bartlett et al., 2004). Given 
previous studies examining the properties and utility of the PPL, and the ability of the 
statistic to take advantage of phenotypically defined subgroups, we believe that the results 
we present here most accurately reflect the evidence for linkage in our data. Furthermore, 
based on 3600 simulated sib-pair datasets, we have observed PPLs greater than 10% only 
0.4% of the time in the absence of true underlying linkage (pointwise significance), which is 
consistent with previous studies in extended pedigrees (Logue and Vieland, 2004). We will 
only come to know with certainty, however, whether the PPLs that we describe in this report 
are real or not by continuing to update our analyses with data from additional autism 
datasets. We therefore look forward to applying the PPL to alternative phenotypes, and to 
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incorporating additional samples of families into our analyses as genotyping from those 
samples becomes available.
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Multipoint posterior probability of linkages (PPLs) for combined Collaborative Linkage 
Study of Autism Set 1 and 2 families. The PPLs for this analysis were updated over the two 
language-based subgroups as described in Methods.
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Collaborative Linkage Study of Autism multipoint posterior probability of linkages (PPLs) 
for selected chromosomes. These graphs present the multipoint PPL for the four strongest 
linkage signals. These scores are derived from PPL updating over four groups of families: 
Set 1 phrase speech delay (PSD) positive and PSD negative, and Set 2 PSD positive and 
PSD negative, and also incorporating classification of parents based on whether or not they 
reported a history of a developmental language impairment (see Methods). The sex-
averaged genetic map provided by Marshfield was used to plot cM location.
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Table 1






Set 1 40 (70) 17 (30)
Set 2 36 (63) 21 (37)
Language impaired Parents (%) (28) (28)
CLSA, Collaborative Linkage Study of Autism; PPL, posterior probability of linkage; PSD +, phrase speech delay positive; PSD −, phrase speech 
delay negative.
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